{"id":4013,"date":"2022-02-22T19:04:33","date_gmt":"2022-02-22T19:04:33","guid":{"rendered":"https:\/\/www.ariadnelabs.org\/annualreport\/?page_id=4013"},"modified":"2023-10-17T12:31:35","modified_gmt":"2023-10-17T12:31:35","slug":"financials","status":"publish","type":"page","link":"https:\/\/www.ariadnelabs.org\/2022annualreport\/financials\/","title":{"rendered":"Financials"},"content":{"rendered":"
\n
<\/div><\/div>\n\n
\n\n

Ariadne\u2019s programmatic work continued to grow in FY22, with grant revenue increasing by $1.47 million. Amid economic uncertainty that drove a nationwide trend toward decreased philanthropic giving, gifts brought in $1.3 million less than anticipated. Miscellaneous expenses increased by $700,000, due largely to consulting expenses related to interim staffing for essential staff roles. <\/p>\n\n\n\n

Operating losses were offset by a $3.38 million reduction in expenses from FY21. We headed into FY23 with a positive financial outlook, anticipating increased levels of grant funding to further offset expenses.<\/p>\n\n<\/div><\/div>\n\n

<\/div><\/div>\n<\/div>\n\n\n
<\/div>\n\n\n\n
<\/td>FISCAL YEAR ’20<\/strong><\/td>FY ’21<\/strong><\/td>FY ’22<\/strong><\/td><\/tr>
Revenue ($ Millions)<\/strong><\/td>$27.8<\/strong><\/td>$27.0<\/strong><\/td>$19.5<\/strong><\/td><\/tr>
Expenses ($ Millions)<\/strong><\/td>$25.7<\/strong><\/td>$25.1<\/strong><\/td>$21.7<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
<\/div>\n\n\n\n
\n
\n

FY22 Revenue and Expenses<\/h4>\n\n\n\n
<\/div>\n\n\n
\n
\"\"<\/figure>\n<\/div>\n\n\n

<\/p>\n<\/div>\n\n\n\n

\n

FY22 Revenue by Source \u2014 $19.5M<\/h4>\n\n\n\n
<\/div>\n\n\n\n
\"\"<\/figure>\n\n\n\n
<\/div>\n\n\n\n

FY22 Expenditure by Type \u2014 $21.7M<\/h4>\n\n\n\n
<\/div>\n\n\n\n
\"\"<\/figure>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n

FY22 Revenue by Source – $19.5M<\/h4>\n\n\n\n
<\/div>\n\n\n\n
Non-Federal Grants & Contracts<\/td>9,140,059<\/td><\/tr>
Federal Grants<\/td>1,247,740<\/td><\/tr>
Gifts<\/td>4,925,337<\/td><\/tr>
IDC & Gift Fees<\/td>3,092,242<\/td><\/tr>
Other Revenue<\/td>37,353<\/td><\/tr>
Capital Contributions<\/td>1,118,830<\/td><\/tr>
<\/td>19,561,563<\/td><\/tr><\/tbody><\/table><\/figure>\n<\/div>\n\n\n\n
\n

FY22 Expenditure by Type – $21.7M<\/h4>\n\n\n\n
<\/div>\n\n\n\n
Direct Salary & Fringe<\/td>12,439,689<\/td><\/tr>
Subcontracts\/Professional Services<\/td>2,081,488<\/td><\/tr>
Real Estate<\/td>1,232,308<\/td><\/tr>
Other Misc Expense<\/td>1,218,252<\/td><\/tr>
10% Admin Fees<\/td>1,697,174<\/td><\/tr>
IDC & Gift Fees<\/td>3,092,242<\/td><\/tr>
<\/td>21,761,153<\/td><\/tr><\/tbody><\/table><\/figure>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
<\/div>\n\n\n
\n
<\/div><\/div>\n\n
\n\n
\n
< SPREAD<\/a><\/div>\n<\/div>\n\n<\/div><\/div>\n\n
\n\n
\n
Supporters & Board ><\/a><\/div>\n<\/div>\n\n<\/div><\/div>\n\n
<\/div><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

FISCAL YEAR ’20 FY ’21 FY ’22 Revenue ($ Millions) $27.8 $27.0 $19.5 Expenses ($ Millions) $25.7 $25.1 $21.7 FY22 Revenue and Expenses FY22 Revenue by Source \u2014 $19.5M FY22 Expenditure by Type \u2014 $21.7M FY22 Revenue by Source – $19.5M Non-Federal Grants & Contracts 9,140,059 Federal Grants 1,247,740 Gifts 4,925,337 IDC & Gift Fees … Read more<\/a><\/p>\n","protected":false},"author":10,"featured_media":6445,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-4013","page","type-page","status-publish","has-post-thumbnail"],"_links":{"self":[{"href":"https:\/\/www.ariadnelabs.org\/2022annualreport\/wp-json\/wp\/v2\/pages\/4013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ariadnelabs.org\/2022annualreport\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ariadnelabs.org\/2022annualreport\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ariadnelabs.org\/2022annualreport\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ariadnelabs.org\/2022annualreport\/wp-json\/wp\/v2\/comments?post=4013"}],"version-history":[{"count":44,"href":"https:\/\/www.ariadnelabs.org\/2022annualreport\/wp-json\/wp\/v2\/pages\/4013\/revisions"}],"predecessor-version":[{"id":7411,"href":"https:\/\/www.ariadnelabs.org\/2022annualreport\/wp-json\/wp\/v2\/pages\/4013\/revisions\/7411"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ariadnelabs.org\/2022annualreport\/wp-json\/wp\/v2\/media\/6445"}],"wp:attachment":[{"href":"https:\/\/www.ariadnelabs.org\/2022annualreport\/wp-json\/wp\/v2\/media?parent=4013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}